CRYSTAL CHATMAN-BROWN: Open Payments
NPI 1851309710 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 25 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $553 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $113 |
| Exact Sciences Corporation | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Abbott Laboratories | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
Products named: JARDIANCE, Kerendia, REXULTI, MOUNJARO, SHINGRIX, The Cologuard Plus Collection Kit, GEMTESA, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
